Svlsf Iv, Llc - Net Worth and Insider Trading

Svlsf Iv, Llc Net Worth

The estimated net worth of Svlsf Iv, Llc is at least $48 Million dollars as of 2024-11-13. Svlsf Iv, Llc is the 10% Owner of Ocular Therapeutix Inc and owns about 4,486,298 shares of Ocular Therapeutix Inc (OCUL) stock worth over $48 Million. Details can be seen in Svlsf Iv, Llc's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Svlsf Iv, Llc has not made any transactions after 2015-06-10 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Svlsf Iv, Llc

To

Svlsf Iv, Llc Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Svlsf Iv, Llc owns 6 companies in total, including KalVista Pharmaceuticals Inc (KALV) , Entellus Medical Inc (ENTL) , and Ocular Therapeutix Inc (OCUL) among others .

Click here to see the complete history of Svlsf Iv, Llc’s form 4 insider trades.

Insider Ownership Summary of Svlsf Iv, Llc

Ticker Comapny Transaction Date Type of Owner
KALV KalVista Pharmaceuticals Inc 2018-12-19 10 percent owner
ENTL Entellus Medical Inc 2017-01-31 10 percent owner
OCUL Ocular Therapeutix Inc 2015-06-10 10 percent owner
LIMIT LIMIT 2013-09-24 10 percent owner
LIMIT LIMIT 2013-09-03 10 percent owner
LIMIT LIMIT 2010-05-03 10 percent owner

Svlsf Iv, Llc Latest Holdings Summary

Svlsf Iv, Llc currently owns a total of 1 stock. Svlsf Iv, Llc owns 4,486,298 shares of Ocular Therapeutix Inc (OCUL) as of June 10, 2015, with a value of $48 Million.

Latest Holdings of Svlsf Iv, Llc

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
OCUL Ocular Therapeutix Inc 2015-06-10 4,486,298 10.60 47,554,759

Holding Weightings of Svlsf Iv, Llc


Svlsf Iv, Llc Form 4 Trading Tracker

According to the SEC Form 4 filings, Svlsf Iv, Llc has made a total of 0 transactions in Ocular Therapeutix Inc (OCUL) over the past 5 years. The most-recent trade in Ocular Therapeutix Inc is the sale of 1,119,000 shares on June 10, 2015, which brought Svlsf Iv, Llc around $25 Million.

Insider Trading History of Svlsf Iv, Llc

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Svlsf Iv, Llc Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Svlsf Iv, Llc Ownership Network

Ownership Network List of Svlsf Iv, Llc

No Data

Ownership Network Relation of Svlsf Iv, Llc

Insider Network Chart

Svlsf Iv, Llc Owned Company Details

What does KalVista Pharmaceuticals Inc do?

Who are the key executives at KalVista Pharmaceuticals Inc?

Svlsf Iv, Llc is the 10 percent owner of KalVista Pharmaceuticals Inc. Other key executives at KalVista Pharmaceuticals Inc include CFO and Secretary Benjamin L Palleiko , Chief Medical Officer Paul K. Audhya , and Chief Development Officer Christopher Yea .

KalVista Pharmaceuticals Inc (KALV) Insider Trades Summary

Over the past 18 months, Svlsf Iv, Llc made no insider transaction in KalVista Pharmaceuticals Inc (KALV). Other recent insider transactions involving KalVista Pharmaceuticals Inc (KALV) include a net purchase of 1,251,017 shares made by Venrock Healthcare Capital Partners Iii, L.p. , a net sale of 144,760 shares made by Benjamin L Palleiko , and a net sale of 116,267 shares made by Edward P. Feener .

In summary, during the past 3 months, insiders sold 40,693 shares of KalVista Pharmaceuticals Inc (KALV) in total and bought 0 shares, with a net sale of 40,693 shares. During the past 18 months, 583,370 shares of KalVista Pharmaceuticals Inc (KALV) were sold and 1,251,017 shares were bought by its insiders, resulting in a net purchase of 667,647 shares.

KalVista Pharmaceuticals Inc (KALV)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

KalVista Pharmaceuticals Inc Insider Transactions

No Available Data

Svlsf Iv, Llc Mailing Address

Above is the net worth, insider trading, and ownership report for Svlsf Iv, Llc. You might contact Svlsf Iv, Llc via mailing address: One Boston Place, 201 Washington Street, Suite 3900, Boston Ma 02108.